UK markets open in 42 minutes

Axsome Therapeutics, Inc. (0HKF.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
74.09-0.27 (-0.36%)
At close: 02:34PM BST
Full screen
Previous close74.36
Open0.00
Bid0.00 x 0
Ask0.00 x 0
Day's range0.00 - 0.00
52-week range
Volume240
Avg. volume562
Market cap23.953M
Beta (5Y monthly)1.10
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Insider Monkey

    15 Most Black States in the US

    In this article, we will be taking a look at the 15 most black states in the US. If you do not want to learn about the demographics of global black population, head straight to the 5 Most Black States in the US. Overview of the Global Black Population: Demographics, Trends, and Immigration Patterns The […]

  • Zacks

    Axsome (AXSM) Begins Solriamfetol Binge Eating Phase III Study

    Axsome's (AXSM) phase III ENGAGE study is set to evaluate the efficacy and safety of solriamfetol for the treatment of binge eating disorder in adults.

  • GuruFocus.com

    Insider Sell: COO Mark Jacobson Sells 24,662 Shares of Axsome Therapeutics Inc (AXSM)

    Axsome Therapeutics Inc (NASDAQ:AXSM), a biopharmaceutical company focused on developing novel therapies for the management of central nervous system (CNS) disorders, has reported an insider sell according to a recent SEC filing.